(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

Biodesix, Inc. (NASDAQ: BDSX) shares fell Friday. The Louisville, Colo-based company, a leading diagnostics solutions concern, announced the publication of the largest lung nodule biomarker clinical ...

Please provide your email address to receive an email when new articles are posted on . The negative predictive value of a biomarker that detects benign vs. malignant nodules was more than 90% in men ...

Please provide your email address to receive an email when new articles are posted on . Researchers did not find noninferiority when comparing less with more intensive module surveillance. They also ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

The proposed CNN-based system demonstrates the feasibility and robustness of deep learning for automatic lung nodule detection and classification. Despite strong results, the study acknowledges ...

Indeterminate pulmonary nodules in patients diagnosed with osteosarcoma present a challenge for accurate staging and prognosis. The aim of this study was to explore the significance of this finding.

Radiologists using artificial intelligence (AI)-based software in real clinical practice were better able to detect lung nodules on chest radiographs than radiologists using radiographs alone, ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that three data presentations will ...

PARMA, Ohio -- The lack of protocol regarding lung nodules detected on chest X-rays and CT scans, such as coronary calcium scoring, has led to the opening of a new Lung Nodule Center at University ...